October 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The sequencing consumables market, crucial for DNA/RNA sequencing, supports DNA-based therapeutics, diagnostics, and research. It is driven by rising demand in personalized medicine and cancer treatment. Trends include Illumina's new global center in Bengaluru and Alithea Genomics’ $3.2M funding in 2024....
November 01, 2025
The upstream bioprocessing market is growing rapidly, driven by advancements in cell culture and process efficiency. It involves culturing cells in bioreactors to develop proteins, crucial for biopharmaceuticals. Policies like India's BioE3 and sustainable innovations are boosting the sector's growth globally....
November 01, 2025
Projections indicate that, the global virus filtration market will increase from USD 5.22 billion in 2024 to USD 13.7 billion by 2034, experiencing a CAGR of 10.5% over the next 10 years. The rapidly expanding biotechnology sector, increasing manufacturing of biotech products, and technological advancements drive the market....
November 01, 2025
The miRNA sequencing and assay market is growing with advancements in next-gen sequencing (NGS) to explore miRNA's role in gene regulation and disease. Recent funding rounds, like aceRNA's $6.1M raise and Regulus' $100M deal, highlight innovations. AI integration, like Biostate AI's RNAseq tools, further accelerates research....
November 01, 2025
Based on market forecasts, the global cell counting market, projected at USD 10.24 billion in 2024, is expected to reach USD 22.85 billion by 2034, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incorporating cell counts into flow cytometry is an easy way to improve test results and potentially save...
November 01, 2025
According to forecasts, the global metabolomics market will grow from USD 3.21 billion in 2024 to USD 11.32 billion by 2034, with an expected CAGR of 13.43%. The growth of the metabolomics market is driven by the ability to provide details of metabolic states and global biochemical events affecting cells or biological systems....
November 01, 2025
The multiomics market is advancing with key funding rounds: PrognomiQ raised $34M (Nov 2024) to enhance disease monitoring, and Freenome secured $254M (Feb 2024) for early cancer detection tests. AI integration drives breakthroughs in data analysis, precision medicine, and drug discovery (e.g., MultiOmic Health)....
November 01, 2025
Gene expression involves converting genetic information into functional RNA or proteins, vital in healthcare for disease insights and drug discovery. North America leads the market, driven by funding and advancements, while Asia-Pacific grows rapidly with government support and biopharma innovations....
November 01, 2025
The medical biomimetics market size is calculated at $38.59 bn in 2025 is to hit $74.87 bn by 2034. Medical biomimetics combines biology and technology to create innovative healthcare solutions, like biomaterials for tissue engineering, regenerative medicine, and drug delivery. Advances in R&D, biotech, and partnerships, such as Edwards Li...
November 01, 2025
Optical Genome Mapping (OGM) is advancing diagnostics for hematological malignancies and genetic diseases with its ability to detect complex genetic variations quickly and affordably. Highlighted at ASH 2024, its role in cancer research grows. AI integration further enhances genomics by analyzing vast data efficiently....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com